bioRxivCancer Biology
NNT Regulates Mitochondrial Metabolism in NSCLC Through Maintenance of Fe-S Protein Function
N. P. Ward, Y. P. Kang, A. Falzone, T. A. Boyle, G. M. DeNicola
Abstract
Human lung tumors exhibit robust and complex mitochondrial metabolism, likely precipitated by the highly oxygenated nature of pulmonary tissue. As ROS generation is a byproduct of this metabolism, reducing power in the form of nicotinamide adenine dinucleotide phosphate (NADPH) is required to mitigate oxidative stress in response to this heightened mitochondrial activity. Nicotinamide nucleotide transhydrogenase (NNT) is known to sustain mitochondrial antioxidant capacity through the generation of NADPH, however its function in non-small cell lung cancer (NSCLC) has not been established. We found that NNT expression significantly enhances tumor formation and aggressiveness in mouse models of lung tumor initiation and progression. We further show that NNT loss elicits mitochondrial dysfunction independent of substantial increases in oxidative stress, but rather marked by the diminished activities of proteins dependent on resident iron-sulfur clusters. These defects were associated with both NADPH availability and ROS accumulation, suggesting that NNT serves a specific role in mitigating the oxidation of these critical protein cofactors.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Mitochondrial Function is Preserved Under Cysteine Starvation via Glutathione Catabolism in NSCLC
N. P. Ward, S. J. Yoon, … G. M. DeNicola·bioRxiv·Oct 6, 2022
- Plasma redox imbalance caused by albumin oxidation promotes lung-predominant NETosis and pulmonary cancer metastasis
M. Inoue, M. Enomoto, … S. V. Bratman·bioRxiv·Feb 28, 2018
- MNRR1 is required for Triple Negative Breast Cancer growth and metastasis and can be targeted by repurposed drugs.
Mrunal Sathe, Paige M. Minchella, … Siddhesh Aras·bioRxiv·Feb 3, 2026
- Cysteine dioxygenase 1 is a metabolic liability for non-small cell lung cancer
Y. P. Kang, L. Torrente, … G. M. DeNicola·bioRxiv·Nov 1, 2018
- Oxidized protein states define metastatic fitness in lung cancer
Maolin Ge, Magdy Gohar, … Liron Bar‐Peled·bioRxiv·Jul 19, 2026
- RESPIRATION DEFECTS LIMIT SERINE SYNTHESIS REQUIRED FOR LUNG CANCER GROWTH AND SURVIVAL
Eduardo Cararo Lopes, Fuqian Shi, … Eileen White·Nature CommunicationsPeer-reviewed·Aug 15, 2025